跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NAPROXENO INFECTOPHARM 50 MG/ML SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NAPROXENO INFECTOPHARM 50 MG/ML SUSPENSION ORAL
Approved
STANDARD
NAPROXENO INFECTOPHARM 50 MG/ML SUSPENSION ORAL
Infectopharm Arzneimittel Und Consilium Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 21, 2021
Approval ID
8c340eca3607bb7f
Company
Infectopharm Arzneimittel Und Consilium Gmbh
Type
Standard
Approval Details
Approval Id
8c340eca3607bb7f
Drug Cima Aemps Name
NAPROXENO INFECTOPHARM 50 MG/ML SUSPENSION ORAL
Register Number
86455
Holder Company Name
Infectopharm Arzneimittel Und Consilium Gmbh
Marketing Company Name
Infectopharm Arzneimittel Und Consilium Gmbh
Holder Company Detail Path
/organization/infectopharm-arzneimittel-und-consilium-gmbh
Marketing Company Detail Path
/organization/infectopharm-arzneimittel-und-consilium-gmbh
Authorization Date
2021-12-21
Dosage Form
SUSPENSIÓN ORAL
Dose
50 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Infectopharm Arzneimittel Und Consilium Gmbh
Company Detail Path
/organization/infectopharm-arzneimittel-und-consilium-gmbh
Company Information
Pharmaceutical Company Name
InfectoPharm Arzneimittel und Consilium GmbH
Country Name
Austria
City Name
wien,wien,country_at
Address
Leopold-Ungar-Platz 2/1.Stk/Stg.2
Active Ingredients
NAPROXENO
50 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 21, 2021
Approval ID
8c340eca3607bb7f
Type
Standard
Back to CIMA-AEMPS Approvals